OXYMETAZOLINE 0,05 MEDIRITE


METERED NASAL SPRAY 10 mL
scheduling status
S1
registration number
47/16.1/0791
What OXYMETAZOLINE 0,05 MEDIRITE is and what it is used for
OXYMETAZOLINE 0,05 MEDIRITE is indicated for adults and children over 6 years to relieve a blocked nose due to the common cold (acute rhinitis), sinusitis (inflammation or swelling of the tissue lining the sinuses), hay fever (allergic rhinitis), or as an add-on treatment for middle ear infection.
dosage
OXYMETAZOLINE MEDIRITE 0,05: Adults: 1 to 2 sprays into each nostril 2 to 3 times a day Children over 6 years: 1 spray into each nostril 2 to 3 times a day. OXYMETAZOLINE MEDIRITE 0,05 is not intended for children below the age of 6 years (see Do not use OXYMETAZOLINE MEDIRITE). The single dose given for OXYMETAZOLINE MEDIRITE 0,05 must not be administered more than 3 times a day.
how to take
OXYMETAZOLINE MEDIRITE 0,05 metered spray is indicated for adults and children over 6 years. Do not use OXYMETAZOLINE 0,05 MEDIRITE for more than 5 days (see Warnings and precautions"). Do not exceed the recommended dosage. If symptoms persist, consult a health care provider. For best results keep both the head and spray bottle in an upright position. Remove the cap by pulling and insert the nozzle of the spray loosely into the nostril with the middle and forefinger around the bottom of the nozzle and the thumb on the base of the bottle. Depress the spray mechanism thus producing a fine mist. Sniff in to ensure an even distribution of the spray. Withdraw from nostril and release the spray mechanism. Repeat for the other nostril. Prevention of contamination: - Wipe the tip of the applicator with a clean, damp tissue and replace the cap directly after use. - Do not share your bottle of OXYMETAZOLINE 0,05 MEDIRITE with other people.
What OXYMETAZOLINE 0,05 MEDIRITE contains
Oxymetazoline hydrochloride.
other ingredients
Benzalkonium chloride 0,01 % m/v Disodium hydrogen phosphate dihydrate Liquid sorbitol 70 % Sodium dihydrogen phosphate dihydrate (for pH adjustment) Water for injection.
Therapeutic classification
R01AA05.
© 2026 SAHPRA. ALL RIGHTS RESERVED